Self-assembled heptamethine cyanine dye dimer as a novel theranostic drug delivery carrier for effective image-guided chemo-photothermal cancer therapy

J Control Release. 2021 Jan 10:329:50-62. doi: 10.1016/j.jconrel.2020.11.046. Epub 2020 Nov 28.

Abstract

Near-infrared (NIR)-induced dye-based theranostic drug delivery carriers are used for critical image-guided chemo-photothermal cancer therapy. However, most carriers fail to deliver sufficient heat and fluorescence efficiently due to direct π-π stacking of the aromatic rings of the NIR dye and drug. In the work reported herein, we examined a self-assembled heptamethine cyanine dye dimer (CyD) with improved heat and fluorescence delivery that was developed by manipulating the unique structural and optical properties of the dimer. The H-aggregation of CyD in an aqueous solution generated a great amount of heat by transforming the energy of the excited electrons into non-radiative energy. Moreover, the disulfide bond of CyD assisted nanoparticles with a drug by minimizing the interaction between the NIR dye and drug, and also by releasing the drug in a redox environment. As a result, DOX encapsulated within CyD (CyD/DOX) showed strong heat generation and fluorescence imaging in tumor-bearing mice, allowing detection of the tumor site and inhibition of tumor growth by chemo-photothermal therapy. The multiplicity of features supplied by the newly developed CyD demonstrated the potential of CyD/DOX as an NIR dye-based theranostic drug-delivery carrier for effective chemo-photothermal cancer therapy.

Keywords: Chemo-photothermal therapy; Heptamethine cyanine dye dimer; Near-infrared fluorescence imaging; Theranostic drug delivery carrier.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Doxorubicin
  • Drug Carriers
  • Drug Delivery Systems
  • Hyperthermia, Induced*
  • Mice
  • Nanoparticles*
  • Neoplasms*
  • Phototherapy
  • Precision Medicine
  • Theranostic Nanomedicine

Substances

  • Drug Carriers
  • Doxorubicin